Search:
Login:
OR

Medical Marijuana

A 'Budtender' Gives Us a Potent Look Inside a Colorado Weed Dispensary

Category: Medical Marijuana | Posted on Sun, May, 1st 2016 by THCFinder

In this week's edition of First-Person Shooter, we gave two cameras to Emily, a Denver-based "budtender" who runs the counter at Magnolia Road, a dispensary that operates both a medical and recreational marijuana storefront, as well as a grow house. A huge weed enthusiast, she smokes about an eighth of dank nug a day, and helps upwards of 300 customers pick out a variety of strains, edibles, and other pot products.

On top of shooting the inside of Magnolia Road, Emily snapped #weedporn-worthy pics of the company's massive warehouse filled with budding buds. She also talked to VICE about the inner-workings of a commercial pot dispensary that she says makes anywhere between $5,000 and $10,000 a day.

Read More:http://www.vice.com/read/first-person-shooter-colorado-weed-dispensary-budtender-photos


Comments

Walgreens Broaches Possible Health Benefits Of Medical Marijuana

Category: Medical Marijuana | Posted on Sat, April, 30th 2016 by THCFinder

Walgreens wants to talk about marijuana.

In what appears to be an unprecedented move for a company its size, Walgreens published a discussion of the possible health benefits of medical marijuana on its health and wellness blog this week.

In the post, titled “Clarifying Clinical Cannabis,” a resident pharmacist at the company takes a look at medical marijuana’s side effects, the debate about its medicinal properties and its legality:

Read More:http://www.huffingtonpost.com/entry/walgreens-medical-marijuana_us_5724dcabe4b0f309baf107c7


Comments

Join NORML In Washington D.C. For Our 2016 National Conference and Congressional Lobby Day

Category: Medical Marijuana | Posted on Sat, April, 30th 2016 by THCFinder

norml scholarships drug policy reform conferenceBy Danielle Keane, NORML Political Director

We are excited to have finalized the agenda for our 2016 National Conference and Congressional Lobby Day! You can check out the full itinerary here.

Day one will include panel discussions on a variety of topics, including the prospects of marijuana law reform in the 114th Congress, the ongoing experience with legalization in Colorado, Washington, and other states, and post prohibition concerns for marijuana consumers. Throughout the day attendees will hear policy experts from NORML, the Marijuana Policy Project, Americans for Safe Access, the National Cannabis Industries Association, and many others

NORML’s Conference seminar takes place on Monday, May 23rd, at the GW Elliot School of International Affairs located at 1957 E Street NW in Washington D.C. Register now here.

Following the seminar, attendees will head to the Mansion on O Street (2020 O St NW) for our NORML Social. Here, attendees will kick back and relax with fellow advocates and share stories of their activism. We will also be holding our 2016 Awards Ceremony, to honor our most dedicated activists and shine light on the hard work they’ve put in throughout the years. You won’t want to miss this event and entry is not included in your general Lobby Day registration. You can purchase a separate ticket to the NORML Social here.

Read More:http://www.theweedblog.com/join-norml-in-washington-d-c-for-our-2016-national-conference-and-congressional-lobby-day/


Comments

Leading Medical Cannabis Expert To Present The Facts Behind A Solution To The Opioid Epidemic

Category: Medical Marijuana | Posted on Fri, April, 29th 2016 by THCFinder
dr dustin sulak

(image via Press Herald)

I received the following press release today. Dr. Dustin Sulak is a very talented, knowledgeable expert. I strongly urge you to check out the event, which is free to all:

One of the world’s leading medical cannabis experts, Dr. Dustin Sulak, will on May 10th, present a free to attend and view seminar that addresses a powerful solution to the opioid addiction epidemic that is sweeping the country.

According to the United States Center For Disease Control:

  • Drug Overdose Death is the leading cause of accidental death in the U.S.
  • In 2014, 61% of U.S. drug overdose deaths involved some type of opioid, including heroin.
  • Each day, 44 people in the United States die from an overdose of prescription painkillers.
  • Each day, almost 7,000 people are treated in emergency departments for using prescription opioid drugs in a manner other than as directed.
  • Between 2013 and 2014, Maine experienced a 27% increase in drug overdose deaths.  Nearly 70% involved an opioid medication. 

Read More:http://www.theweedblog.com/leading-medical-cannabis-expert-to-present-the-facts-behind-a-solution-to-the-opioid-epidemic/


Comments

National Medical Cannabis Advocacy Group Partners with Leading Global Law Firm

Category: Medical Marijuana | Posted on Thu, April, 28th 2016 by THCFinder

Americans For Safe Access press conference detroit michiganOrrick, a leading global law firm, is partnering with Americans for Safe Access’ Patients’ Rights Project to provide pro bono support to medical cannabis patients, many if not most of whom are low-income, to navigate the often confusing legal landscape of medical cannabis laws. Forty-one states, DC, Puerto Rico, and Guam all have some type of medical cannabis law today.  Each law is unique and presents varying challenges for patients trying to obtain treatment in these often complex programs. Once laws are passed, medical cannabis patients and providers are often unclear about the specifics of the laws, which leaves them vulnerable to arrest, prosecution, and incarceration. Furthermore, implementation of these programs has often required litigation. The services provided by this partnership will help fill a growing void for this type of resource.

Founded in 2002, Americans for Safe Access (ASA) is the nation’s largest medical cannabis patient advocacy organization.  For over a decade, ASA has offered educational tools for medical cannabis stakeholders and has worked through legislative advocacy and the court system to broaden patients’ rights to access medical cannabis. ASA identifies impact litigation through data gathered by offering medical cannabis patients legal support and cooperation with pro bono attorneys, including but not limited to, public defender offices. This impact litigation has helped protect and expand patients’ rights and uphold the validity of state medical cannabis programs.

Read More:http://www.theweedblog.com/national-medical-cannabis-advocacy-group-partners-with-leading-global-law-firm/


Comments

Could marijuana help treat painkiller and heroin addiction?

Category: Medical Marijuana | Posted on Tue, April, 26th 2016 by THCFinder

The growing number of patients who claim marijuana has helped them drop theirpainkiller habit has intrigued lawmakers and emboldened advocates. Many are pushing for cannabis as a treatment for the abuse of opioids and illegal narcotics such as heroin, and as an alternative to painkillers.

It's a tempting sell in New England, hard hit by the painkiller and heroin crisis. But there's a problem: There is very little research showing marijuana works as a treatment for such addictions.

Advocates argue a growing body of scientific literature supports the idea, pointing to a study in the Journal of Pain this year that found that chronic pain sufferers significantly reduced their opioid use when taking medical cannabis. Another study, published last year in the Journal of the American Medical Association, found cannabis can be effective in treating chronic pain and other ailments.

Read More:http://www.cbsnews.com/news/could-marijuana-help-treat-painkiller-and-heroin-addiction/


Comments


Search





Blog Categories

Popular Articles

Latest Offers In Your Area
Recent Blog Posts
Download Our App!
10 Miles Away | Los Angeles,
10 Miles Away | Los Angeles,
29.5 Miles Away | La Puente, West,
November 25, 2017 | Category: Fun
November 25, 2017 | Category: Videos
November 25, 2017 | Category: News
Mobile Apps
Copyright 2017 THCFinder.com
All Rights Reserved.
Dispensaries      Strains      About Us      Friends      API / Widgets      Privacy Policy      Terms of Use      Investors      Contact Us